Last month, BEL software SOURCERER achieved FDA 510(k) clearance. “FDA clearance of SOURCERER has been a major goal of our team and for the BEL Quality Management System,” said Dr. Don Tucker, CEO and Founder of BEL Company, and of Neurosom. BEL Company was founded in 2017 after a successful sale of a previous company […]
This is a guest blog in collaboration with Nocturnal, a product development firm specializing in Class II and Class III medical devices and offering fixed-price projects to minimize the risk of time and budget overruns. Translating a groundbreaking concept into a commercially viable medical device requires navigating a complex web of challenges, from securing funding […]
Diversifying your portfolio when investing in private companies is crucial for managing risk while aiming for higher returns. Alternative assets like private equity, venture capital, and real estate often present higher risks due to their illiquidity and market volatility, but they also offer the potential for substantial rewards. By incorporating a mix of high-risk, high-reward […]
The Food and Drug Administration (FDA) plays a crucial role in ensuring the safety and effectiveness of medical devices in the United States. One of the key ways the FDA regulates these devices is through a classification system that determines the level of regulatory control necessary to ensure their safety and effectiveness. This classification system […]
Introducing Cannulight to RedCrow’s Discover Platform! We sat down with James Stone, the inventor, founder, and CEO of Cannulight, to learn more about the company and its mission. In a few sentences, describe your company, product, and innovation.Cannulight is a small, sterile, single use, disposable medical device that aids peripheral intra venous cannulation/catheterization (PIVC). Cannulight gives an […]
Equity crowdfunding has transformed the investment landscape, providing opportunities for companies seeking capital and investors looking to participate in early-stage ventures. However, within this realm, various regulations govern the process, offering distinct opportunities and limitations. To understand their nuances for companies and investors, let’s delve into three significant regulations—RegCF, RegA+, and RegD 506(c). Regulation Crowdfunding […]
In investing, distinctions between accredited and non-accredited investors carry substantial weight, particularly within the dynamic landscape of equity crowdfunding. Let’s explore the avenues of equity crowdfunding accessible to each category. Accredited Investors vs. Non-Accredited Investors Accredited Investors: Accredited investors are individuals or entities meeting stringent criteria stipulated by regulatory bodies like the Securities and Exchange […]
5 Questions with MARAbio Founder & Chief Science Advisor, Dr. Judy Van de Water Breakthroughs in the study of a sub-type of autism are powering a new area of precision-medicine to change the future of autism. MARAbio’s pioneering Founder & Chief Science Advisor shares her thoughts on what’s at stake and what’s in store. Guest […]
Guest Post by Michael G. Nathans, CEO and Co-Founder at WhisperSom Corporation Researchers have found that diabetes and ADHD in children as well as heart attacks, strokes, and Alzheimer’s Disease in adults are linked to unmanaged sleep apnea. Why? Because regular breathing while asleep is as important as having a regular heartbeat—and sleep apnea disrupts a person’s […]
Guest Post by Andrew Dahl of NOXBOX Concussions are a mild to moderate traumatic brain injury (TBI) that can have serious long-term effects on the brain. The effects of a concussion can range from mild to severe and can last for days, weeks, or even months. Unfortunately, concussions are often difficult to diagnose. Delayed concussion […]
Site Disclaimer
Want to learn more about investing in Regulation Crowdfunding (Reg CF)? Access our investor educational material here.
Important Disclosures
The www.RedCrow.com website (the “Website” or “Site”) is operated by Red Crow Crowd Inc. (“RedCrow”) and owned by Alira Health Transaction Services. Sections of this website are used by Alira Health Transaction Services (FINRA CRD No. 140203), which is a registered broker-dealer and a member of FINRA | SIPC. Information on all FINRA registered broker-dealers can be found on FINRA’s BrokerCheck. All securities-related activity is conducted by Alira Health Transaction Services, located at 1 Grant St, Framingham, Massachusetts 01702. Neither RedCrow or Alira Health Transaction Services provides investment advice or makes investment recommendations on this website; nothing posted on the Site should be construed as such. No communication, through this website or in any other sections of this website or medium should be construed as a recommendation for any security offered on or off this investment platform.
Alternative investments are speculative, involve a high degree of risk and are not suitable for all investors and you should not invest unless you are able to sustain the risk of loss of your entire investment. Complete loss of principal is possible. Private placements are unregistered securities, considered illiquid and long-term investments. Distributions are not guaranteed. Investing in securities involves risks, and there is always the potential of losing money when you invest in securities.
Content provided is for informational purposes only and is not intended to be an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities or a solicitation of any such offer. Information provided does not take into account an investor’s specific objectives or risk profile. Investment decisions should be made based on your objectives and circumstances and in consultation with your own advisors. Alira Health Transaction Services does not provide tax, legal or accounting advice. Please consult with and rely on a qualified professional.
By accessing this website and any pages thereof, you agree to be bound by the Terms of Use.
Form CRS | Regulation Best Interest | Business Continuity Plan | Privacy Policy | Electronic Delivery Consent.
